Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Tempus AI, Inc. secures up to $9.5 million in funding from ARPA-H to develop the first autonomous clinical AI agent for cardiology. This funding will help advance AI applications for patients with heart failure.
PUBLIC · TEMSep 09, 2026•about 3 hours ago
Amount Raised
$9.5 Million
Round Type
Venture - Series Unknown
ChicagoOtherBiotechnologyInvestors
Arpa H
Description
Tempus AI, Inc. announced it has been awarded up to $9.5 million by ARPA-H to develop an autonomous clinical AI agent. This project aims to enhance care for patients suffering from heart failure. The funding is part of ARPA-H's ADVOCATE initiative
Don't miss Tempus AI's next move
Get an email the moment Tempus AI raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contactVerified contactsTED L., Director hidden hidden hidden
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tempus AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.